Anatomical ConceptsTraining & Education

Part 2 · Chapter 5

What the Research Shows

What You Will Learn

  • The key findings from the RISE programme and other research
  • How muscle mass, tissue quality, and function improved with treatment
  • Why starting early produces the best results, though it is rarely too late
  • What the evidence does not yet tell us

1. Does It Work?

For anyone considering electrical stimulation for denervated muscle, the fundamental question is straightforward: Does it work? The answer, based on the evidence, is yes, with important nuances.

The most comprehensive evidence comes from the EU RISE programme, led by Helmut Kern and colleagues. This programme enrolled twenty-five people with complete lower motor neuron lesions (permanent denervation with no prospect of nerve regrowth), twenty of whom completed the full two years, and demonstrated measurable improvements across multiple outcomes. The treatment was done at home, for up to 30 minutes per muscle group, five days a week. This was not a passive therapy, and where people's commitment slipped, their gains slipped with it. What made the evidence particularly compelling was that it went beyond simply measuring whether muscles got bigger. The researchers took muscle biopsies and used advanced imaging to see exactly what was happening inside the tissue.

Is it safe and is it effective

2. What the RISE Programme Found

Electrical stimulation rescued muscle bulk and tissue quality.

Muscle mass

The headline finding was a 35 per cent increase in quadriceps (thigh muscle) cross-sectional area after two years of home-based electrical stimulation, measured by CT scanning. In muscles permanently disconnected from their nerve supply, this represented a substantial reversal of the wasting process.

Tissue structure

The biopsy evidence was, in many ways, even more compelling than the imaging. After treatment, muscle biopsies showed that the contractile machinery inside the fibres (the structures that produce force), which had largely broken down, had been rebuilt: in most patients the majority of fibres had regained their striped structure, and in the longest-treated patients nine out of ten fibres had. The internal coupling system between the electrical signal and calcium release, described in Chapter 1, was rebuilt alongside it. This was not cosmetic swelling; it was genuine structural restoration.

An unexpected bonus was that muscles not directly targeted also changed. Stimulation aimed at the quadriceps was accompanied by a 15 per cent increase in hamstring size, probably because the electrical field spreads to neighbouring muscles, although this change was not large enough to be statistically certain. The skin under the electrodes recovered too: after two years its outer layer was 39 per cent thicker, a benefit that is particularly important for people at risk of pressure injuries.

Force and function

Muscle force output improved dramatically, to roughly thirteen times the starting level, although the starting level was very low. Some people gained enough strength to support FES-assisted standing in parallel bars. Five of the twenty people who completed the two years, a quarter of them, achieved this milestone, a genuine functional achievement for people with complete lower motor neuron lesions.

Independent confirmation

Encouragingly, these findings are not limited to a single research group. The Swiss Paraplegic Centre and the Richmond VA Medical Centre in the United States have both reported positive results with long-pulse stimulation in people with denervated muscle after spinal cord injury, using their own patients and protocols, independently of the Vienna programme. This independent replication strengthens confidence in the findings.

3. When to Start: The Evidence on Timing

One of the most important findings from the research concerns timing. As we revealed in Part 1, Earlier intervention consistently produces better outcomes, but it is rarely too late to start.

Patients who began treatment within the first year after injury achieved the best results. Across the whole group, most of the growth in muscle size came in the first year of treatment (about 24 per cent, with a smaller further gain in the second year), and on both scans and biopsies the recovery was greatest in those who started earliest. The biological reasons are clear: in the early months, the muscle retains much of its internal architecture, its stem cell reserves are still relatively intact, and the tissue is most responsive to stimulation.

In the chronic phase, for patients starting two or more years after injury, outcomes were reduced but still meaningful. The Vienna group now describe a denervated muscle as being largely replaced by fat and fibrous tissue three to six years after the injury, and the further along that road a muscle has travelled, the harder restoration becomes; the one person in the study who started eight years after injury responded far less. Even so, after prolonged denervation, skin quality improves and measurable gains in muscle mass are observed. In our experience, we have seen meaningful progress in people who started years after their injury. It simply takes longer and requires more patience.

The key message: start as early as possible, but do not assume the door is closed if you are learning about this for the first time, years after your injury.

4. Evidence Beyond Spinal Cord Injury

While the RISE programme focused on spinal cord injury, the principles apply wherever denervation occurs.

For brachial plexus injuries and other peripheral nerve injuries, the evidence comes from a different angle: preserving the muscle while waiting for the nerve to regrow, and helping that regrowth along. Small randomised trials have shown that a single hour of stimulation delivered at the time of nerve surgery improves the number and quality of nerve-to-muscle reconnections. These trials were in less severe nerve injuries of the hand and wrist rather than in brachial plexus injury itself, so the evidence is promising rather than definitive. Separately, a Swiss study in people with tetraplegia confirmed that twelve weeks of direct stimulation, five days a week, thickened denervated hand and forearm muscles using the same long-pulse principle as the RISE work.

For facial palsy, a 2026 analysis of 13 trials found that adding electrical stimulation in the early weeks reduced the rate of incomplete recovery by about 35 per cent compared with standard treatment alone. That benefit is clearest in mild to moderate palsy; in severe cases, how much stimulation to give in the early phase, and when, are still open questions. This is covered in detail in Chapter 12.

5. How Progress Is Measured

If you undergo this treatment, your clinician will use several methods to track your progress.

A strength-duration test is the most specific measure. Your clinician places an electrode on the muscle and delivers pulses of varying durations. This test shows exactly how your muscle responds and whether its electrical properties are improving over time. As treatment progresses, the muscle should respond to progressively shorter pulses, a direct sign that the tissue is recovering.

Limb girth measurements using a tape measure are the simplest way to track changes in muscle size. Measuring the circumference of your thigh or arm at consistent points over time shows whether the muscle is growing. In our experience, people who see their measurements increasing are significantly more committed to continuing their programme.

Tissue quality is assessed by feel. A denervated muscle that is responding to treatment develops a firmer, more defined quality compared to the soft, flaccid feel of untreated tissue.

Photographs taken at regular intervals provide a visual record that complements the measurements. People often do not notice gradual changes in their own bodies; comparison photographs taken months apart can reveal significant and motivating changes.

6. What the Evidence Does Not Yet Tell Us

The evidence has genuine limitations that deserve acknowledgement.

Most of the evidence comes from a single research network (the Vienna group), though independent replication is now emerging. There is no large randomised controlled trial in the specific population (chronic, permanent denervation) where the evidence is strongest. Long-term follow-up data beyond the RISE study period are limited. We do not yet know definitively whether people maintain their gains if they reduce their treatment intensity, or exactly how long treatment needs to continue.

These are real limitations, but they are the kind that characterise many areas of rehabilitation medicine, where populations of affected individuals are relatively small, treatments are complex, and timelines are long. They are reasons for continued research, not for withholding a treatment that has demonstrated clear benefit.


Chapter Summary

The RISE programme demonstrated clinically meaningful improvements in muscle mass (35 per cent increase), tissue structure (the contractile machinery inside most fibres rebuilt), force production, and functional capacity in people with permanent denervation. These findings are confirmed by biopsy and imaging data and are being independently replicated. Earlier intervention produces the best results, but later intervention still produces measurable benefits. The evidence extends beyond spinal cord injury to peripheral nerve injuries, including brachial plexus injuries, and to facial palsy. The evidence has genuine limitations, including the absence of large randomised trials and limited long-term follow-up, but these are reasons for further research, not for withholding treatment.


Ready to find out if electrical stimulation could help?

Contact Anatomical Concepts to discuss your situation with a specialist.

Contact AC